AlphaYouML
Insider buying
Mark Lappe bought $999K of Inhibrx Biosciences, Inc. (INBX) stock
Mark Lappe, Chief Executive Officer of Inhibrx Biosciences, Inc. (INBX), bought 10,000 shares of INBX stock worth $999K, per an SEC Form 4 filed Sep 28, 2026.
It was an open-market purchase.
The trade happened on Sep 25, 2026, 3 days before it was made public.
INBX has moved +0.0% since the trade date, from $99.61 to $99.61 (Sep 25, 2026 close).
- Traded
- Sep 25, 2026
- Disclosed
- Sep 28, 2026
- Filing delay
- 3 days
- Price since
- +0.0%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More INBX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.